On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.

The European Commission has approved the topical pan-JAK inhibitor delgocitinib for adults with moderate to severe hand ...

Deerfield-based Baxter International has temporarily closed its largest manufacturing plant following damage caused by ...

Organizations and groups continue to raise awareness regarding breast cancer. However, an important update from a federal ...

By Melissa Patrick Kentucky Health News Hurricane Helene brought power outages across the state, which means Kentuckians need ...

The Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), making it the first major ...

An examination of the Federal Circuit’s decision in In re Cellect, LLC, which held that patents awarded Patent Term ...

California Gov. Gavin Newsom over the weekend signed Assembly Bill 660 into law, which standardizes food package labeling. It ...

A new law will go into effect in Louisiana on Oct. 1 that will classify two drugs—mifepristone and misoprostol, which are ...

Project 2025 aims to “abolish the Deep State and return government to the people.” Its 922-page policy guidebook outlines ...

While the U.S. Drug Enforcement Administration is on track to reclassify marijuana as a less dangerous drug, efforts at both ...